TLR2 and colon adenocarcinoma: In this study, we investigated the impact of genetic variation in TLR1 and TLR2, which are the receptors for HMGB1, on the clinical outcomes of colon carcinoma (COAD) patients who underwent postoperative adjuvant chemotherapy, specifically those with regional lymph node metastatic COAD.